P3 Health Partners Inc. (PIII) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 2 Buy, 2 Hold.
The consensus price target is $12.50, representing an upside of 406.1% from the current price $2.47.
Analysts estimate Earnings Per Share (EPS) of $-28.01 and revenue of $1.51B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-46.79 vs est $-28.01 (missed -67%). 2025: actual $-45.26 vs est $-29.98 (missed -51%). Analyst accuracy: 63%.
PIII Stock — 12-Month Price Forecast
$12.50
▲ +406.07% Upside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for P3 Health Partners Inc., the price target is $12.50.
The average price target represents a +406.07% change from the last price of $2.47.
PIII Analyst Ratings
Buy
Based on 4 analysts giving stock ratings to P3 Health Partners Inc. in the past 3 months
EPS Estimates — PIII
63%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual –$46.79
vs Est –$28.01
▼ 40.1% off
2025
Actual –$45.26
vs Est –$29.98
▼ 33.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — PIII
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.500B
vs Est $1.508B
▼ 0.5% off
2025
Actual $1.459B
vs Est $1.428B
▲ 2.1% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
